Cyclin D1 expression in usual hyperplasia, atypical ductal hyperplasia and low nuclear grade ductal carcinoma in situ of the breast: an immunohistochemical study

被引：0
|
作者：
Monaghan, H
Scott, D
Schrimankar, J
Bell, H
Marsh, A
McIntosh, GG
Angus, B
机构：
[1] Univ Edinburgh, Sch Med, Dept Pathol, Edinburgh EH8 9YL, Midlothian, Scotland
[2] Royal Victoria Infirm, Dept Pathol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England
[3] Royal Victoria Infirm, Dept Surg, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England
来源：
JOURNAL OF PATHOLOGY | 1999年 / 187卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：25A / 25A
页数：1
相关论文
共 50 条
  • [1] Cyclin D1 expression in ductal carcinoma in situ, atypical ductal hyperplasia and usual ductal hyperplasia:: An immunohistochemical study
    Umekita, Y
    Yoshida, H
    PATHOLOGY INTERNATIONAL, 2000, 50 (07) : 527 - 530
  • [2] Cyclin D1 and associated proteins in mammary ductal carcinoma in situ and atypical ductal hyperplasia
    Gillett, CE
    Lee, AHS
    Millis, RR
    Barnes, DM
    JOURNAL OF PATHOLOGY, 1998, 184 (04): : 396 - 400
  • [3] Expression of cyclins in ductal hyperplasia, atypical ductal hyperplasia and ductal carcinoma in situ of the breast
    Kim, HJ
    Jung, WH
    Kim, DY
    Lee, HD
    YONSEI MEDICAL JOURNAL, 2000, 41 (03) : 345 - 353
  • [4] Expression of ALDH1 in atypical ductal hyperplasia, carcinoma, usual ductal hyperplasia and normal breast duct
    Guan, Xin
    Han, Lu
    Dong, Yi
    Li, Wenlong
    Li, Yi
    Vantreese, Angela
    Bi, Lirong
    Zhao, Peng
    Fan, Zhimin
    Shi, Aiping
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (07): : 7174 - 7182
  • [5] Estrogen Receptor and Cytokeratin 5 Are Reliable Markers to Separate Usual Ductal Hyperplasia From Atypical Ductal Hyperplasia and Low-Grade Ductal Carcinoma In Situ
    Martinez, Anthony P.
    Cohen, Cynthia
    Hanley, Krisztina Z.
    Li, Xiaoxian
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2016, 140 (07) : 686 - 689
  • [6] Usual ductal hyperplasia of the breast is a committed stem (progenitor) cell lesion distinct from atypical ductal hyperplasia and ductal carcinoma in situ
    Boecker, W
    Moll, R
    Dervan, P
    Buerger, H
    Poremba, C
    Diallo, RI
    Herbst, H
    Schmidt, A
    Lerch, MM
    Buchwalow, IB
    JOURNAL OF PATHOLOGY, 2002, 198 (04): : 458 - 467
  • [7] Thymidine kinase 1 expression in atypical ductal hyperplasia significantly differs from usual ductal hyperplasia and ductal carcinoma in situ: A useful tool in tumor therapy management
    Guan, Hong
    Sun, Yanhua
    Zan, Qin
    Xu, Meiquan
    Li, Yuan
    Zhou, Ji
    He, Ellen
    Eriksson, Staffan
    Wen, Wen
    Skog, Sven
    MOLECULAR MEDICINE REPORTS, 2009, 2 (06) : 923 - 929
  • [8] Expression of cyclin-dependent kinase inhibitor, p27 in ductal carcinoma in situ and atypical ductal hyperplasia of breast
    Kohli, A
    Mohtasham, F
    Wuu, J
    Reale, F
    Khan, A
    MODERN PATHOLOGY, 1998, 11 (01) : 22A - 22A
  • [9] Atypical ductal hyperplasia and ductal carcinoma in situ of the breast associated with perineural invasion
    Gobbi, H
    Jensen, RA
    Simpson, JF
    Olson, SJ
    Page, DL
    HUMAN PATHOLOGY, 2001, 32 (08) : 785 - 790
  • [10] Computational Image Analysis of Nuclear Morphology Distinguishes Ductal Carcinoma In Situ from Usual Ductal Hyperplasia of the Breast
    Dong, F.
    Lerwill, M. F.
    Brachtel, E. F.
    Knoblauch, N. W.
    Montaser-Kouhsari, L.
    Jones, N. C.
    Wilbur, D. C.
    Beck, A. H.
    LABORATORY INVESTIGATION, 2014, 94 : 45A - 46A
12345